Desferrioxamine-related ocular toxicity: A case report.
Indian J Ophthalmol
;
2012 Jul-Aug; 60(4): 315-317
Artículo
en Inglés
| IMSEAR
| ID: sea-144860
ABSTRACT
A 29-year-old lady receiving repeated blood transfusions for β thalassemia since childhood, presented with rapidly deteriorating symptoms of night blindness and peripheral visual field loss. She was recently commenced on high-dose intravenous desferrioxamine for reducing the systemic iron overload. Clinical and investigative findings were consistent with desferrioxamine-related pigmentary retinopathy and optic neuropathy. Recovery was partial following cessation of desferrioxamine. This report highlights the ocular side-effects of desferrioxamine mesylate and the need to be vigilant in patients on high doses of desferrioxamine.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Enfermedades de la Retina
/
Transfusión Sanguínea
/
Femenino
/
Humanos
/
Talasemia beta
/
Adulto
/
Deferoxamina
Idioma:
Inglés
Revista:
Indian J Ophthalmol
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS